Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy
Copyright policy )Coronavirus Disease 2019 (COVID-19) Pandemic and Pregnancy
(Am J Obstet Gynecol. 2020;222:521–531) Caring for vulnerable populations is a critical component of pandemic management. Pregnant women are susceptible to respiratory illness with an increased infectious morbidity and mortality. While clinical information is limited on the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on the pregnant population, both the SARS-CoV and MERS-CoV outbreaks of the last 2 decades resulted in approximately one third of infected pregnant women dying from the illness. The purpose of this paper was to summarize the clinical features of coronavirus disease 2019 (COVID-19) in pregnant women, and present a pragmatic and integrated framework for handling complex intricacies involved in disease management.
- National University Hospital Singapore
- National University of Health Sciences United States
- National University of Singapore Libraries Singapore
- Universidad de Bogotá Jorge Tadeo Lozano Colombia
- National University of Singapore Singapore
PNEUMONIA, coronavirus, remdesivir, Respiratory failure, susceptibility, chloroquine, sepsis, MERS-CoV, Baricitinib, RESPIRATORY SYNDROME CORONAVIRUS, Pregnancy, INFECTION, Obstetrics and Gynaecology, baricitinib, Pregnancy Complications, Infectious, fever, OUTCOMES, MOTHERS, Obstetrics & Gynecology, Chloroquine, SARS-CoV, antiviral, Virus, respiratory distress syndrome, Obstetrics, Breast Feeding, Female, pregnancy, Coronavirus Infections, Life Sciences & Biomedicine, Fever, Respiratory distress syndrome, Pneumonia, Viral, Remdesivir, 610, virus, 618, Betacoronavirus, LOPINAVIR/RITONAVIR, Síndrome respiratorio agudo grave, MERS-CoV,morbidity, Sepsis, Humans, Antiviral, Mortality, Special Report, Pandemics, Personal Protective Equipment, SARS, Obstetric management, Science & Technology, Pandemic, Mask, SARS-CoV-2, pandemic, respiratory failure, COVID-19, Delivery, Obstetric, mortality, Infectious Disease Transmission, Vertical, Coronavirus, mask, MERS-COV, Susceptibility, Morbidity, NEONATES BORN, obstetric management
PNEUMONIA, coronavirus, remdesivir, Respiratory failure, susceptibility, chloroquine, sepsis, MERS-CoV, Baricitinib, RESPIRATORY SYNDROME CORONAVIRUS, Pregnancy, INFECTION, Obstetrics and Gynaecology, baricitinib, Pregnancy Complications, Infectious, fever, OUTCOMES, MOTHERS, Obstetrics & Gynecology, Chloroquine, SARS-CoV, antiviral, Virus, respiratory distress syndrome, Obstetrics, Breast Feeding, Female, pregnancy, Coronavirus Infections, Life Sciences & Biomedicine, Fever, Respiratory distress syndrome, Pneumonia, Viral, Remdesivir, 610, virus, 618, Betacoronavirus, LOPINAVIR/RITONAVIR, Síndrome respiratorio agudo grave, MERS-CoV,morbidity, Sepsis, Humans, Antiviral, Mortality, Special Report, Pandemics, Personal Protective Equipment, SARS, Obstetric management, Science & Technology, Pandemic, Mask, SARS-CoV-2, pandemic, respiratory failure, COVID-19, Delivery, Obstetric, mortality, Infectious Disease Transmission, Vertical, Coronavirus, mask, MERS-COV, Susceptibility, Morbidity, NEONATES BORN, obstetric management
citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).982 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 0.01% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Top 0.1% impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 0.01%
Citations provided by BIP!Popularity provided by BIP!